Express News | Wuhan Hiteck Biological Pharma: The company has added the production scope for suppository pharmaceutical production to its pharmaceutical production license.

BreakingsDec 27, 2024 15:51

Express News | The opening of the tenth batch of national Pharmaceutical centralized purchasing has prompted nearly 30 listed companies to announce their products are likely to be selected after the market close.

BreakingsDec 13, 2024 21:24

Wuhan Hiteck Biological Pharma (300683.SZ): Injection of rohitidine hydrochloride acetate and ketoconazole injection is expected to be selected for the national Pharmaceutical centralized procurement.

Wuhan Hiteck Biological Pharma (300683.SZ) announced that the company participated in the national organization of pharmaceutical joint procurement office's tenth...

Zhitong FinanceDec 13, 2024 16:38

Express News | Wuhan Hiteck Biological Pharma: Two Pharmaceuticals intended to be selected for national pharmaceutical procurement.

BreakingsDec 13, 2024 16:22

Express News | On the 13th, the stock equity registration took place, with Bestechnic (Shanghai) Co., Ltd., Xiamen Bank Co., Ltd., and Deshi Co., Ltd. offering the highest dividend strength.

BreakingsDec 11, 2024 08:12

Wuhan Hiteck Biological Pharma (300683.SZ): Plans to distribute a cash dividend of 1.3 yuan for every 10 shares to all shareholders.

On December 10, Geelong Hu announced that Wuhan Hiteck Biological Pharma (300683.SZ) disclosed that the Board of Directors has drafted the profit distribution plan for the first half of 2024 under the premise of adhering to the profit distribution principles and ensuring the normal Operation and long-term development of the company. Based on a total share capital of 130,894,391 shares as of the disclosure date of this announcement, it is proposed to distribute a cash dividend of 1.30 yuan (tax included) for every 10 shares to all Shareholders, totaling a cash dividend distribution of 17,016,270.83 yuan (tax included). This profit distribution does not increase the share capital, nor is there a bonus issue.

Gelonghui FinanceDec 10, 2024 19:07